Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Neurology"
DOI: 10.1007/s00415-018-9011-8
Abstract: Idarucizumab can completely reverse the biological activity of dabigatran within a few minutes [1]. Several reports have documented thrombolytic therapy following antagonism of dabigatran with idarucizumab, and various arrangements have been made in different countries… read more here.
Keywords: plasma dabigatran; dabigatran; concentration; antagonism ... See more keywords